DRAFT FDA Executive Summary

First Page		Document Content
Health Electrotherapy Treatment of bipolar disorder Neurophysiology Medical equipment Cranial electrotherapy stimulation Transcranial magnetic stimulation Management of depression Transcranial direct-current stimulation Medicine Psychiatry Neurotechnology		DRAFT FDA Executive Summary Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 637,50 KB Share Document on Facebook

	Medication Guide Antidepressant Medicines, Depression and other Serious Mental Illnesses, and Suicidal Thoughts or Actions DocID: 1rlMD - View Document
	24. März 2016 FINANCIAL SERVICES OVERVIEW Complete transparency of DocID: 1rk8W - View Document
	U.S. SOCCER NATIONAL TEAMS CONCUSSION EVALUATION & MANAGEMENT PROTOCOLS The Return To Play (RTP) decision-making process after concussion is one of the most complicated in sports medicine. Despite ongoing research, the c DocID: 1qHSN - View Document
	A QEEG Database Method for Predicting Pharmacotherapeutic Outcome in Refractory Major Depressive Disorders Stephen C. Suffin, M.D. W. Hamlin Emory, M.D. Nicholas Gutierrez, M.D. DocID: 1qAQC - View Document
	Selective Serotonin Reuptake Inhibitor (SSRI) Drugs: More Risks Than Benefits? Benefits of SSRIs Joel M. Kauffman, Ph.D. DocID: 1pY1S - View Document